Skip to Main Content

GENEVA — Novartis CEO Joseph Jimenez will step down early next year and be replaced by fellow American Dr. Vasant Narasimhan, the Swiss pharmaceutical company said Monday.

Narasimhan, currently its chief medical officer and global head of drug development, will take over the top job on Feb. 1, Novartis said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED